MILLER STRATEGIES, LLC

Lobbying for ALZHEON, INC. · Biopharmaceutical

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

Health Issues

Issues related to FDA drug approval process and therapies for Alzheimer's disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.